Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Nemazee

Showing results (61-70 of 124) with videos related to

Pageof 13
Sort By:
The Journal of Applied Laboratory Medicine|June 25, 2021
SARS-CoV-2 Serology Status Detected by Commercialized Platforms Distinguishes Previous Infection and Vaccination Adaptive Immune ResponsesRaymond T Suhandynata, Nicholas J Bevins, Jenny T Tran, et al.
Frontiers in Cellular and Infection Microbiology|March 27, 2023
Efficient isolation of rare B cells using next-generation antigen barcodingJonathan Hurtado, Claudia Flynn, Jeong Hyun Lee, et al.
Immunity|December 31, 2017
Precursor Frequency and Affinity Determine B Cell Competitive Fitness in Germinal Centers, Tested with Germline-Targeting HIV Vaccine ImmunogensRobert K Abbott, Jeong Hyun Lee, Sergey Menis, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 14, 2019
Immunogenicity of RNA Replicons Encoding HIV Env Immunogens Designed for Self-Assembly into NanoparticlesMariane Melo, Ely Porter, Yuan Zhang, et al.
Frontiers in Immunology|June 7, 2023
Fusion of the molecular adjuvant C3d to cleavage-independent native-like HIV-1 Env trimers improves the elicited antibody responseShridhar Bale, Lifei Yang, Mehrdad Alirezaei, et al.
Plos Pathogens|December 4, 2020
A natural mutation between SARS-CoV-2 and SARS-CoV determines neutralization by a cross-reactive antibodyNicholas C Wu, Meng Yuan, Sandhya Bangaru, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2010
A mutation of Ikbkg causes immune deficiency without impairing degradation of IkappaB alphaOwen M Siggs, Michael Berger, Philippe Krebs, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 18, 2010
Deletion of IgG-switched autoreactive B cells and defects in Fas(lpr) lupus miceDjemel Aït-Azzouzene, Dwight H Kono, Rosana Gonzalez-Quintial, et al.
Science Immunology|August 5, 2022
Asymmetrical forward and reverse developmental trajectories determine molecular programs of B cell antigen receptor editingMichael K Okoreeh, Domenick E Kennedy, Akinola Olumide Emmanuel, et al.
Nature Communications|June 29, 2016
Presenting native-like trimeric HIV-1 antigens with self-assembling nanoparticlesLinling He, Natalia de Val, Charles D Morris, et al.
Pageof 13

Showing results (61-70 of 124) with videos related to

Sort By:
Pageof 13
The Journal of Applied Laboratory Medicine|June 25, 2021
SARS-CoV-2 Serology Status Detected by Commercialized Platforms Distinguishes Previous Infection and Vaccination Adaptive Immune ResponsesRaymond T Suhandynata, Nicholas J Bevins, Jenny T Tran, et al.
Frontiers in Cellular and Infection Microbiology|March 27, 2023
Efficient isolation of rare B cells using next-generation antigen barcodingJonathan Hurtado, Claudia Flynn, Jeong Hyun Lee, et al.
Immunity|December 31, 2017
Precursor Frequency and Affinity Determine B Cell Competitive Fitness in Germinal Centers, Tested with Germline-Targeting HIV Vaccine ImmunogensRobert K Abbott, Jeong Hyun Lee, Sergey Menis, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 14, 2019
Immunogenicity of RNA Replicons Encoding HIV Env Immunogens Designed for Self-Assembly into NanoparticlesMariane Melo, Ely Porter, Yuan Zhang, et al.
Frontiers in Immunology|June 7, 2023
Fusion of the molecular adjuvant C3d to cleavage-independent native-like HIV-1 Env trimers improves the elicited antibody responseShridhar Bale, Lifei Yang, Mehrdad Alirezaei, et al.
Plos Pathogens|December 4, 2020
A natural mutation between SARS-CoV-2 and SARS-CoV determines neutralization by a cross-reactive antibodyNicholas C Wu, Meng Yuan, Sandhya Bangaru, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 6, 2010
A mutation of Ikbkg causes immune deficiency without impairing degradation of IkappaB alphaOwen M Siggs, Michael Berger, Philippe Krebs, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 18, 2010
Deletion of IgG-switched autoreactive B cells and defects in Fas(lpr) lupus miceDjemel Aït-Azzouzene, Dwight H Kono, Rosana Gonzalez-Quintial, et al.
Science Immunology|August 5, 2022
Asymmetrical forward and reverse developmental trajectories determine molecular programs of B cell antigen receptor editingMichael K Okoreeh, Domenick E Kennedy, Akinola Olumide Emmanuel, et al.
Nature Communications|June 29, 2016
Presenting native-like trimeric HIV-1 antigens with self-assembling nanoparticlesLinling He, Natalia de Val, Charles D Morris, et al.
Pageof 13